Your browser doesn't support javascript.
loading
Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis.
Fernandes-Serodio, João; Prieto-González, Sergio; Espígol-Frigolé, Georgina; Ríos-Garcés, Roberto; Gómez-Caverzaschi, Verónica; Araújo, Olga; Espinosa, Gerard; Jordà-Sánchez, Raül; Alba, Marco A; Quintana, Luis; Blasco, Miquel; Guillen, Elena; Viñas, Odette; Ruiz-Ortiz, Estíbaliz; Pelegrín, Laura; Sainz de la Maza, Maite; Sánchez-Dalmau, Bernardo; García-Herrera, Adriana; Solé, Manel; Castillo, Paola; Aldecoa, Iban; Cano, María D; Sellarés, Jacobo; Hernández-González, Fernanda; Agustí, Carlos; Lucena, Carmen M; López-Rueda, Antonio; Sánchez, Marcelo; Benegas, Mariana; Capurro, Sebastián; Sanmartí, Raimon; Grau, Josep M; Vilaseca, Isabel; Alobid, Isam; Cid, Maria C; Hernández-Rodríguez, José.
Afiliação
  • Fernandes-Serodio J; Department of Autoimmune Diseases, Vasculitis Research Unit, Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Spanish Center of the Centros, Servicios y Unidades de Referencia (CSUR) and Catalan Center of the Xarxa d'Unitats d
  • Prieto-González S; Systemic Immuno-mediated Diseases Unit (UDIMS), Department of Internal Medicine IV, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal.
  • Espígol-Frigolé G; Department of Autoimmune Diseases, Vasculitis Research Unit, Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Spanish Center of the Centros, Servicios y Unidades de Referencia (CSUR) and Catalan Center of the Xarxa d'Unitats d
  • Ríos-Garcés R; Department of Autoimmune Diseases, Vasculitis Research Unit, Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Spanish Center of the Centros, Servicios y Unidades de Referencia (CSUR) and Catalan Center of the Xarxa d'Unitats d
  • Gómez-Caverzaschi V; Department of Autoimmune Diseases, Vasculitis Research Unit, Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Spanish Center of the Centros, Servicios y Unidades de Referencia (CSUR) and Catalan Center of the Xarxa d'Unitats d
  • Araújo O; Department of Autoimmune Diseases, Vasculitis Research Unit, Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Spanish Center of the Centros, Servicios y Unidades de Referencia (CSUR) and Catalan Center of the Xarxa d'Unitats d
  • Espinosa G; Department of Autoimmune Diseases, Vasculitis Research Unit, Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Spanish Center of the Centros, Servicios y Unidades de Referencia (CSUR) and Catalan Center of the Xarxa d'Unitats d
  • Jordà-Sánchez R; Department of Autoimmune Diseases, Vasculitis Research Unit, Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Spanish Center of the Centros, Servicios y Unidades de Referencia (CSUR) and Catalan Center of the Xarxa d'Unitats d
  • Alba MA; Department of Autoimmune Diseases, Vasculitis Research Unit, Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Spanish Center of the Centros, Servicios y Unidades de Referencia (CSUR) and Catalan Center of the Xarxa d'Unitats d
  • Quintana L; Department of Autoimmune Diseases, Vasculitis Research Unit, Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Spanish Center of the Centros, Servicios y Unidades de Referencia (CSUR) and Catalan Center of the Xarxa d'Unitats d
  • Blasco M; Department of Nephrology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Guillen E; Department of Nephrology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Viñas O; Department of Nephrology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Ruiz-Ortiz E; Department of Immunology, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.
  • Pelegrín L; Department of Immunology, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.
  • Sainz de la Maza M; Department of Ophthalmology, Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Sánchez-Dalmau B; Department of Ophthalmology, Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • García-Herrera A; Department of Ophthalmology, Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Solé M; Department of Anatomic Pathology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Castillo P; Department of Anatomic Pathology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Aldecoa I; Department of Anatomic Pathology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Cano MD; Department of Anatomic Pathology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Sellarés J; Department of Anatomic Pathology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Hernández-González F; Department of Pulmonary Medicine, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Agustí C; Department of Pulmonary Medicine, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Lucena CM; Department of Pulmonary Medicine, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • López-Rueda A; Department of Pulmonary Medicine, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Sánchez M; Interventional Neuroradiology Unit, Department of Radiology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Benegas M; Department of Radiology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Capurro S; Department of Radiology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Sanmartí R; Department of Radiology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Grau JM; Department of Rheumatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Vilaseca I; Department of Internal Medicine, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Alobid I; Department of Otorhinolaryngology, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Cid MC; Department of Otorhinolaryngology, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Hernández-Rodríguez J; Department of Autoimmune Diseases, Vasculitis Research Unit, Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Spanish Center of the Centros, Servicios y Unidades de Referencia (CSUR) and Catalan Center of the Xarxa d'Unitats d
J Intern Med ; 295(5): 651-667, 2024 May.
Article em En | MEDLINE | ID: mdl-38462959
ABSTRACT

BACKGROUND:

Microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) are the two major antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

OBJECTIVES:

To characterize a homogenous AAV cohort and to assess the impact of clinicopathological profiles and ANCA serotypes on clinical presentation and prognosis. Clinical differences in GPA patients according to ANCA serotype and the diagnostic yield for vasculitis of biopsies in different territories were also investigated.

RESULTS:

This retrospective study (2000-2021) included 152 patients with AAV (77 MPA/75 GPA). MPA patients (96.1% myeloperoxidase [MPO]-ANCA and 2.6% proteinase 3 [PR3]-ANCA) presented more often with weight loss, myalgia, renal involvement, interstitial lung disease (ILD), cutaneous purpura, and peripheral nerve involvement. Patients with GPA (44% PR3-ANCA, 33.3% MPO, and 22.7% negative/atypical ANCA) presented more commonly with ear, nose, and throat and eye/orbital manifestations, more relapses, and higher survival than patients with MPA. GPA was the only independent risk factor for relapse. Poor survival predictors were older age at diagnosis and peripheral nerve involvement. ANCA serotypes differentiated clinical features in a lesser degree than clinical phenotypes. A mean of 1.5 biopsies were performed in 93.4% of patients in different territories. Overall, vasculitis was identified in 80.3% (97.3% in MPA and 61.8% in GPA) of patients.

CONCLUSIONS:

The identification of GPA presentations associated with MPO-ANCA and awareness of risk factors for relapse and mortality are important to guide proper therapeutic strategies in AAV patients. Biopsies of different affected territories should be pursued in difficult-to-diagnose patients based on their significant diagnostic yield.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Granulomatose com Poliangiite / Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos / Poliangiite Microscópica Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Granulomatose com Poliangiite / Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos / Poliangiite Microscópica Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article